采用扶正抗癌汤联合FOLFOX4治疗晚期胃癌对提高治疗安全性与患者生存质量的临床可靠性分析

探究扶正抗癌汤联合FOLFOX4应用于治疗晚期胃癌中对提高治疗安全性与患者生存质量的临床效果。方法:选取我院收治的70例晚期胃癌患者,随机分为观察组患者和对照组患者,两组实验对象均为35例。对照组患者仅应用 FOLFOX4 方式治疗,观察组患者采用扶正抗癌汤结合FOLFOX4治疗方式。观察分析两组患者的临床治疗效果、毒副作用情况以及生活质量情况。结果:70例患者分别接受治疗后,观察组患者临床症状评分低于对照组患者,且生活质量评分总有效率高于对照组患者,差异有统计学意义(P<0.05)。观察组患者毒副作用0、Ⅰ、Ⅱ、Ⅲ、Ⅳ度分别为8例、18例、6例、3例、0例;对照组患者毒副作用0、Ⅰ、Ⅱ、Ⅲ、Ⅳ度分别为3例、8例、11例、8例、5例,观察组毒副反应的分度轻于对照组,差异有统计学意义(P<0.05)。结论:晚期胃癌患者采用扶正抗癌汤结合FOLFOX4治疗,治疗效果显著,且安全性较高,能够提高患者生活质量和生存质量,值得在临床治疗中继续推广该方案。

Clinical observation of colon carcinoma treated with Boerning capsules plus FOLFOX4 regimen

Objective:To evaluate the effects and adverse reactions of Boerning capsules plus FOLFOX4 regimen in clinical treatment for colon carcinoma.Methods:Total patients with colon carcinoma were randomly divided into two groups from January 2005 to May 2006:group A(45 patients)were received Boerning capsules plus FOLFOX4 regimen treatment,and group B(49 patients)were received FOLFOX4 regimen treatment only.Results:Boerning capsules could obviously improve the life quality of the colon carcinoma patients.The weight gain in group A was higher than that of group B.No significant existed in the body immune function changes(T cell subgroup).But it could ameliorate the adverse reactions which induced by the chemotherapy.Conclusion:Boerning capsules can improve the life quality of the colon carcinoma patients and ame- liorate the symptoms and sign which induced by the chemotherapy.